Aging is arguably the root cause of most major diseases (loss of function in our cells). Four years ago, we made a bet that aging was treatable, and NewLimit was born.
NewLimit now has a prototype drug that reverses the age of some human cells (restores function they had when they were younger), and a clinical trial scheduled for next year (with more drug candidates in the pipeline).
Grateful to Founders Fund, Thrive, Greenoaks, and the rest of the investors for this latest round. @jacobkimmel and the team are just getting started.
@carmineglitch@HodlHabit You have it opposite imo, we're gonna be dipping in the short term
end of the iran war (confirmed not just reports) is a catalyst
clarity act (despite what people say lmao) will be a catalyst
@TXMCtrades If AI is going to be as destructive to employment as the CEOโs say it will then there is no world where they donโt become nationalized to some extent.
Yes, Rep. Massie.
Reports from Detroit News, Forward, and others confirm AIPAC hosts donor portals on its site routing contributions through Democracy Engine, a third-party processor. Funds pass directly to candidates without AIPAC listed as bundler in FEC disclosures. Campaigns pay processing fees; AIPAC promotes the portals to its donors and gets real-time data. AIPAC calls it standard, like ActBlue. Critics say it exploits a bundling disclosure loophole.